nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.343	1	CiPCiCtD
Desonide—Prednisone—prostate cancer	0.234	1	CrCtD
Desonide—NR3C1—prostate cancer	0.149	1	CbGaD
Desonide—NR3C1—Prednisone—prostate cancer	0.0326	1	CbGbCtD
Desonide—Testolactone—Estrone—prostate cancer	0.0266	0.147	CrCrCtD
Desonide—Ciclesonide—Prednisone—prostate cancer	0.00878	0.0487	CrCrCtD
Desonide—Hydrocortamate—Prednisone—prostate cancer	0.00735	0.0407	CrCrCtD
Desonide—Testolactone—Prednisone—prostate cancer	0.00691	0.0383	CrCrCtD
Desonide—Prednicarbate—Prednisone—prostate cancer	0.00691	0.0383	CrCrCtD
Desonide—Fluocortolone—Prednisone—prostate cancer	0.00671	0.0372	CrCrCtD
Desonide—Alclometasone—Prednisone—prostate cancer	0.00652	0.0362	CrCrCtD
Desonide—Amcinonide—Prednisone—prostate cancer	0.00635	0.0352	CrCrCtD
Desonide—Budesonide—Prednisone—prostate cancer	0.00635	0.0352	CrCrCtD
Desonide—Fludrocortisone—Prednisone—prostate cancer	0.00618	0.0343	CrCrCtD
Desonide—Clobetasol propionate—Prednisone—prostate cancer	0.00618	0.0343	CrCrCtD
Desonide—Diflorasone—Prednisone—prostate cancer	0.00618	0.0343	CrCrCtD
Desonide—Flunisolide—Prednisone—prostate cancer	0.00618	0.0343	CrCrCtD
Desonide—Paramethasone—Prednisone—prostate cancer	0.00603	0.0334	CrCrCtD
Desonide—Desoximetasone—Prednisone—prostate cancer	0.00588	0.0326	CrCrCtD
Desonide—Fluorometholone—Prednisone—prostate cancer	0.00574	0.0319	CrCrCtD
Desonide—Mometasone—Prednisone—prostate cancer	0.00574	0.0319	CrCrCtD
Desonide—Triamcinolone—Prednisone—prostate cancer	0.00574	0.0319	CrCrCtD
Desonide—Loteprednol—Prednisone—prostate cancer	0.00574	0.0319	CrCrCtD
Desonide—Fluprednidene Acetate—Prednisone—prostate cancer	0.00574	0.0319	CrCrCtD
Desonide—Betamethasone—Prednisone—prostate cancer	0.00561	0.0311	CrCrCtD
Desonide—Dexamethasone—Prednisone—prostate cancer	0.00561	0.0311	CrCrCtD
Desonide—Rimexolone—Prednisone—prostate cancer	0.00561	0.0311	CrCrCtD
Desonide—Methylprednisolone—Prednisone—prostate cancer	0.00537	0.0298	CrCrCtD
Desonide—Prednisolone—Prednisone—prostate cancer	0.00526	0.0291	CrCrCtD
Desonide—Hydrocortisone—Prednisone—prostate cancer	0.00504	0.028	CrCrCtD
Desonide—NR3C1—urine—prostate cancer	0.000692	0.348	CbGeAlD
Desonide—NR3C1—Regulation of Androgen receptor activity—TMPRSS2—prostate cancer	0.000516	0.0364	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—HOXB13—prostate cancer	0.000439	0.031	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA3—prostate cancer	0.000386	0.0273	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—KLK3—prostate cancer	0.000333	0.0235	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—SPOCK1—prostate cancer	0.000332	0.0235	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—KLF15—prostate cancer	0.000332	0.0235	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA1—prostate cancer	0.000315	0.0222	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—KLK2—prostate cancer	0.000313	0.0221	CbGpPWpGaD
Desonide—NR3C1—prostate gland—prostate cancer	0.000249	0.125	CbGeAlD
Desonide—NR3C1—Endoderm Differentiation—FOXA1—prostate cancer	0.000222	0.0157	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—prostate cancer	0.000221	0.0156	CbGpPWpGaD
Desonide—NR3C1—seminal vesicle—prostate cancer	0.00021	0.106	CbGeAlD
Desonide—NR3C1—SIDS Susceptibility Pathways—NKX3-1—prostate cancer	0.000185	0.0131	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—RXRA—prostate cancer	0.000184	0.013	CbGpPWpGaD
Desonide—NR3C1—epithelium—prostate cancer	0.000183	0.0919	CbGeAlD
Desonide—NR3C1—Endoderm Differentiation—LAMC1—prostate cancer	0.000176	0.0124	CbGpPWpGaD
Desonide—NR3C1—renal system—prostate cancer	0.000169	0.0853	CbGeAlD
Desonide—Amcinonide—ANXA1—prostate cancer	0.000167	0.081	CrCbGaD
Desonide—NR3C1—urethra—prostate cancer	0.000166	0.0837	CbGeAlD
Desonide—NR3C1—Adipogenesis—KLF6—prostate cancer	0.000162	0.0115	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—LIFR—prostate cancer	0.000162	0.0115	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—MT2A—prostate cancer	0.000161	0.0114	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—PENK—prostate cancer	0.000153	0.0108	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—LAMC1—prostate cancer	0.000153	0.0108	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—prostate cancer	0.000151	0.0107	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—prostate cancer	0.000146	0.0103	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—HNF1B—prostate cancer	0.000143	0.0101	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—BMP7—prostate cancer	0.000143	0.0101	CbGpPWpGaD
Desonide—Upper respiratory tract infection—Conjugated Estrogens—prostate cancer	0.000139	0.00318	CcSEcCtD
Desonide—NR3C1—Adipogenesis—ID3—prostate cancer	0.000138	0.00974	CbGpPWpGaD
Desonide—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000137	0.00315	CcSEcCtD
Desonide—Pruritus—Estramustine—prostate cancer	0.000136	0.00312	CcSEcCtD
Desonide—Hyperglycaemia—Goserelin—prostate cancer	0.000136	0.00312	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—ESR2—prostate cancer	0.000136	0.00957	CbGpPWpGaD
Desonide—Hyperglycaemia—Conjugated Estrogens—prostate cancer	0.000135	0.00309	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—prostate cancer	0.000133	0.00942	CbGpPWpGaD
Desonide—Infestation NOS—Conjugated Estrogens—prostate cancer	0.000133	0.00305	CcSEcCtD
Desonide—Infestation—Conjugated Estrogens—prostate cancer	0.000133	0.00305	CcSEcCtD
Desonide—Irritability—Estradiol—prostate cancer	0.000132	0.00303	CcSEcCtD
Desonide—Cough—Bicalutamide—prostate cancer	0.000132	0.00302	CcSEcCtD
Desonide—Folliculitis—Epirubicin—prostate cancer	0.000132	0.00302	CcSEcCtD
Desonide—Pain—Degarelix—prostate cancer	0.00013	0.00299	CcSEcCtD
Desonide—Pruritus—Estrone—prostate cancer	0.00013	0.00298	CcSEcCtD
Desonide—Sweating—Goserelin—prostate cancer	0.000129	0.00296	CcSEcCtD
Desonide—Mental disorder—Ethinyl Estradiol—prostate cancer	0.000129	0.00295	CcSEcCtD
Desonide—NR3C1—bone marrow—prostate cancer	0.000128	0.0645	CbGeAlD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Bicalutamide—prostate cancer	0.000128	0.00293	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—prostate cancer	0.000128	0.00901	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—ASCL1—prostate cancer	0.000125	0.00882	CbGpPWpGaD
Desonide—Pain—Cabazitaxel—prostate cancer	0.000123	0.00282	CcSEcCtD
Desonide—Blood pressure increased—Docetaxel—prostate cancer	0.000123	0.00281	CcSEcCtD
Desonide—Infection—Bicalutamide—prostate cancer	0.000123	0.00281	CcSEcCtD
Desonide—Folliculitis—Doxorubicin—prostate cancer	0.000122	0.00279	CcSEcCtD
Desonide—Rash—Estramustine—prostate cancer	0.000121	0.00278	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—prostate cancer	0.000121	0.00857	CbGpPWpGaD
Desonide—Dermatitis—Estramustine—prostate cancer	0.000121	0.00278	CcSEcCtD
Desonide—Nervous system disorder—Bicalutamide—prostate cancer	0.000121	0.00277	CcSEcCtD
Desonide—Pruritus—Nilutamide—prostate cancer	0.000121	0.00277	CcSEcCtD
Desonide—Headache—Estramustine—prostate cancer	0.000121	0.00276	CcSEcCtD
Desonide—Pruritus—Flutamide—prostate cancer	0.00012	0.00276	CcSEcCtD
Desonide—Pharyngitis—Goserelin—prostate cancer	0.00012	0.00275	CcSEcCtD
Desonide—Skin disorder—Bicalutamide—prostate cancer	0.00012	0.00275	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—AR—prostate cancer	0.00012	0.00846	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—prostate cancer	0.00012	0.00846	CbGpPWpGaD
Desonide—Asthma—Estradiol—prostate cancer	0.00012	0.00274	CcSEcCtD
Desonide—Hyperhidrosis—Bicalutamide—prostate cancer	0.000119	0.00273	CcSEcCtD
Desonide—Oedema peripheral—Goserelin—prostate cancer	0.000119	0.00273	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—prostate cancer	0.000119	0.0084	CbGpPWpGaD
Desonide—Blood pressure increased—Capecitabine—prostate cancer	0.000119	0.00272	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—RXRA—prostate cancer	0.000119	0.00839	CbGpPWpGaD
Desonide—Pharyngitis—Conjugated Estrogens—prostate cancer	0.000119	0.00272	CcSEcCtD
Desonide—Rash—Abiraterone—prostate cancer	0.000118	0.0027	CcSEcCtD
Desonide—Oedema peripheral—Conjugated Estrogens—prostate cancer	0.000118	0.0027	CcSEcCtD
Desonide—Dermatitis—Abiraterone—prostate cancer	0.000118	0.0027	CcSEcCtD
Desonide—Viral infection—Prednisone—prostate cancer	0.000117	0.00269	CcSEcCtD
Desonide—Skin exfoliation—Docetaxel—prostate cancer	0.000117	0.00269	CcSEcCtD
Desonide—Rash—Estrone—prostate cancer	0.000116	0.00266	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—NPPA—prostate cancer	0.000116	0.00818	CbGpPWpGaD
Desonide—Dermatitis—Estrone—prostate cancer	0.000116	0.00266	CcSEcCtD
Desonide—Headache—Estrone—prostate cancer	0.000115	0.00264	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—NCOA2—prostate cancer	0.000114	0.00802	CbGpPWpGaD
Desonide—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000114	0.0026	CcSEcCtD
Desonide—Skin exfoliation—Capecitabine—prostate cancer	0.000113	0.0026	CcSEcCtD
Desonide—Cough—Ethinyl Estradiol—prostate cancer	0.000111	0.00255	CcSEcCtD
Desonide—Upper respiratory tract infection—Estradiol—prostate cancer	0.000111	0.00255	CcSEcCtD
Desonide—NR3C1—Circadian Clock—NCOA2—prostate cancer	0.00011	0.00779	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—ATF3—prostate cancer	0.00011	0.00775	CbGpPWpGaD
Desonide—NR3C1—testis—prostate cancer	0.00011	0.0551	CbGeAlD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	0.000108	0.00247	CcSEcCtD
Desonide—Pruritus—Degarelix—prostate cancer	0.000108	0.00247	CcSEcCtD
Desonide—Hyperglycaemia—Estradiol—prostate cancer	0.000108	0.00247	CcSEcCtD
Desonide—Mediastinal disorder—Conjugated Estrogens—prostate cancer	0.000108	0.00247	CcSEcCtD
Desonide—Rash—Nilutamide—prostate cancer	0.000108	0.00247	CcSEcCtD
Desonide—Dermatitis—Nilutamide—prostate cancer	0.000108	0.00247	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—VDR—prostate cancer	0.000108	0.0076	CbGpPWpGaD
Desonide—Rash—Flutamide—prostate cancer	0.000107	0.00246	CcSEcCtD
Desonide—Dermatitis—Flutamide—prostate cancer	0.000107	0.00246	CcSEcCtD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—prostate cancer	0.000107	0.00757	CbGpPWpGaD
Desonide—Headache—Nilutamide—prostate cancer	0.000107	0.00245	CcSEcCtD
Desonide—Infestation NOS—Estradiol—prostate cancer	0.000107	0.00244	CcSEcCtD
Desonide—Infestation—Estradiol—prostate cancer	0.000107	0.00244	CcSEcCtD
Desonide—Headache—Flutamide—prostate cancer	0.000107	0.00244	CcSEcCtD
Desonide—Mental disorder—Goserelin—prostate cancer	0.000106	0.00242	CcSEcCtD
Desonide—Pain—Bicalutamide—prostate cancer	0.000105	0.00242	CcSEcCtD
Desonide—Erythema—Goserelin—prostate cancer	0.000105	0.00241	CcSEcCtD
Desonide—Mental disorder—Conjugated Estrogens—prostate cancer	0.000105	0.0024	CcSEcCtD
Desonide—Erythema—Conjugated Estrogens—prostate cancer	0.000104	0.00239	CcSEcCtD
Desonide—Rash pustular—Epirubicin—prostate cancer	0.000104	0.00238	CcSEcCtD
Desonide—Upper respiratory tract infection—Mitoxantrone—prostate cancer	0.000104	0.00237	CcSEcCtD
Desonide—Infection—Ethinyl Estradiol—prostate cancer	0.000104	0.00237	CcSEcCtD
Desonide—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000102	0.00234	CcSEcCtD
Desonide—Stinging—Epirubicin—prostate cancer	0.000102	0.00234	CcSEcCtD
Desonide—Skin disorder—Ethinyl Estradiol—prostate cancer	0.000101	0.00232	CcSEcCtD
Desonide—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000101	0.00232	CcSEcCtD
Desonide—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000101	0.00232	CcSEcCtD
Desonide—Skin exfoliation—Prednisone—prostate cancer	0.000101	0.00232	CcSEcCtD
Desonide—NR3C1—Endoderm Differentiation—PTHLH—prostate cancer	0.000101	0.00712	CbGpPWpGaD
Desonide—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000101	0.0023	CcSEcCtD
Desonide—Hyperglycaemia—Mitoxantrone—prostate cancer	0.000101	0.0023	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—prostate cancer	9.76e-05	0.00689	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—EGR1—prostate cancer	9.72e-05	0.00686	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—MIF—prostate cancer	9.65e-05	0.00681	CbGpPWpGaD
Desonide—Rash—Degarelix—prostate cancer	9.62e-05	0.00221	CcSEcCtD
Desonide—Dermatitis—Degarelix—prostate cancer	9.61e-05	0.0022	CcSEcCtD
Desonide—Rash pustular—Doxorubicin—prostate cancer	9.61e-05	0.0022	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—NCOA1—prostate cancer	9.57e-05	0.00676	CbGpPWpGaD
Desonide—Headache—Degarelix—prostate cancer	9.56e-05	0.00219	CcSEcCtD
Desonide—Sweating—Mitoxantrone—prostate cancer	9.52e-05	0.00218	CcSEcCtD
Desonide—Pharyngitis—Estradiol—prostate cancer	9.5e-05	0.00218	CcSEcCtD
Desonide—NR3C1—Nuclear Receptor transcription pathway—AR—prostate cancer	9.46e-05	0.00668	CbGpPWpGaD
Desonide—Stinging—Doxorubicin—prostate cancer	9.46e-05	0.00217	CcSEcCtD
Desonide—Oedema peripheral—Estradiol—prostate cancer	9.43e-05	0.00216	CcSEcCtD
Desonide—NR3C1—Nuclear Receptor transcription pathway—RXRA—prostate cancer	9.39e-05	0.00663	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—NCOA1—prostate cancer	9.29e-05	0.00656	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—prostate cancer	9.27e-05	0.00655	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—EZH2—prostate cancer	9.18e-05	0.00648	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—AR—prostate cancer	9.18e-05	0.00648	CbGpPWpGaD
Desonide—Cough—Goserelin—prostate cancer	9.17e-05	0.0021	CcSEcCtD
Desonide—Viral infection—Epirubicin—prostate cancer	9.17e-05	0.0021	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—prostate cancer	9.16e-05	0.00647	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—RXRA—prostate cancer	9.1e-05	0.00643	CbGpPWpGaD
Desonide—Cough—Conjugated Estrogens—prostate cancer	9.09e-05	0.00208	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—PPARA—prostate cancer	9.07e-05	0.00641	CbGpPWpGaD
Desonide—Headache—Cabazitaxel—prostate cancer	9.01e-05	0.00206	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	8.89e-05	0.00204	CcSEcCtD
Desonide—Pharyngitis—Mitoxantrone—prostate cancer	8.85e-05	0.00203	CcSEcCtD
Desonide—NR3C1—Circadian Clock—RXRA—prostate cancer	8.84e-05	0.00624	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	8.8e-05	0.00202	CcSEcCtD
Desonide—Pruritus—Bicalutamide—prostate cancer	8.72e-05	0.002	CcSEcCtD
Desonide—Mediastinal disorder—Estradiol—prostate cancer	8.63e-05	0.00198	CcSEcCtD
Desonide—Infection—Goserelin—prostate cancer	8.52e-05	0.00195	CcSEcCtD
Desonide—NR3C1—Nuclear Receptor transcription pathway—VDR—prostate cancer	8.5e-05	0.006	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—PRKACB—prostate cancer	8.49e-05	0.006	CbGpPWpGaD
Desonide—Viral infection—Doxorubicin—prostate cancer	8.48e-05	0.00194	CcSEcCtD
Desonide—Infection—Conjugated Estrogens—prostate cancer	8.44e-05	0.00193	CcSEcCtD
Desonide—Nervous system disorder—Goserelin—prostate cancer	8.41e-05	0.00193	CcSEcCtD
Desonide—Mental disorder—Estradiol—prostate cancer	8.39e-05	0.00192	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—prostate cancer	8.37e-05	0.00591	CbGpPWpGaD
Desonide—Nervous system disorder—Conjugated Estrogens—prostate cancer	8.33e-05	0.00191	CcSEcCtD
Desonide—Erythema—Estradiol—prostate cancer	8.33e-05	0.00191	CcSEcCtD
Desonide—Skin disorder—Goserelin—prostate cancer	8.33e-05	0.00191	CcSEcCtD
Desonide—Hyperhidrosis—Goserelin—prostate cancer	8.29e-05	0.0019	CcSEcCtD
Desonide—Infestation NOS—Etoposide—prostate cancer	8.26e-05	0.00189	CcSEcCtD
Desonide—Infestation—Etoposide—prostate cancer	8.26e-05	0.00189	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—TH—prostate cancer	8.25e-05	0.00583	CbGpPWpGaD
Desonide—Skin disorder—Conjugated Estrogens—prostate cancer	8.25e-05	0.00189	CcSEcCtD
Desonide—Irritability—Capecitabine—prostate cancer	8.24e-05	0.00189	CcSEcCtD
Desonide—NR3C1—Nuclear Receptors—ESR1—prostate cancer	8.22e-05	0.00581	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—prostate cancer	8.22e-05	0.00581	CbGpPWpGaD
Desonide—Hyperhidrosis—Conjugated Estrogens—prostate cancer	8.21e-05	0.00188	CcSEcCtD
Desonide—Dermatitis contact—Epirubicin—prostate cancer	8.18e-05	0.00188	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—prostate cancer	8.09e-05	0.00571	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	8.05e-05	0.00569	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—prostate cancer	8.01e-05	0.00566	CbGpPWpGaD
Desonide—NR3C1—lymph node—prostate cancer	7.94e-05	0.0399	CbGeAlD
Desonide—Skin exfoliation—Epirubicin—prostate cancer	7.91e-05	0.00181	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—EGR1—prostate cancer	7.78e-05	0.00549	CbGpPWpGaD
Desonide—Rash—Bicalutamide—prostate cancer	7.78e-05	0.00178	CcSEcCtD
Desonide—Dermatitis—Bicalutamide—prostate cancer	7.77e-05	0.00178	CcSEcCtD
Desonide—Erythema—Mitoxantrone—prostate cancer	7.76e-05	0.00178	CcSEcCtD
Desonide—Headache—Bicalutamide—prostate cancer	7.73e-05	0.00177	CcSEcCtD
Desonide—Dermatitis contact—Doxorubicin—prostate cancer	7.57e-05	0.00174	CcSEcCtD
Desonide—Asthma—Capecitabine—prostate cancer	7.46e-05	0.00171	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—GJA1—prostate cancer	7.4e-05	0.00523	CbGpPWpGaD
Desonide—Pruritus—Ethinyl Estradiol—prostate cancer	7.37e-05	0.00169	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—prostate cancer	7.36e-05	0.0052	CbGpPWpGaD
Desonide—Irritability—Prednisone—prostate cancer	7.34e-05	0.00168	CcSEcCtD
Desonide—Pain—Goserelin—prostate cancer	7.34e-05	0.00168	CcSEcCtD
Desonide—Skin exfoliation—Doxorubicin—prostate cancer	7.32e-05	0.00168	CcSEcCtD
Desonide—Cough—Estradiol—prostate cancer	7.27e-05	0.00167	CcSEcCtD
Desonide—Pain—Conjugated Estrogens—prostate cancer	7.27e-05	0.00167	CcSEcCtD
Desonide—NR3C1—Adipogenesis—AHR—prostate cancer	7.24e-05	0.00512	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—prostate cancer	7.17e-05	0.00506	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	7.05e-05	0.00161	CcSEcCtD
Desonide—Hydrocortisone—ANXA1—prostate cancer	7.03e-05	0.0341	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—ZNF160—prostate cancer	6.97e-05	0.00492	CbGpPWpGaD
Desonide—Upper respiratory tract infection—Capecitabine—prostate cancer	6.93e-05	0.00159	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—prostate cancer	6.9e-05	0.00487	CbGpPWpGaD
Desonide—Infestation NOS—Docetaxel—prostate cancer	6.87e-05	0.00157	CcSEcCtD
Desonide—Infestation—Docetaxel—prostate cancer	6.87e-05	0.00157	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—prostate cancer	6.85e-05	0.00484	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—prostate cancer	6.82e-05	0.00481	CbGpPWpGaD
Desonide—Cough—Mitoxantrone—prostate cancer	6.78e-05	0.00155	CcSEcCtD
Desonide—Infection—Estradiol—prostate cancer	6.76e-05	0.00155	CcSEcCtD
Desonide—NR3C1—Circadian Clock—PPARA—prostate cancer	6.75e-05	0.00477	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—prostate cancer	6.75e-05	0.00477	CbGpPWpGaD
Desonide—Hyperglycaemia—Capecitabine—prostate cancer	6.73e-05	0.00154	CcSEcCtD
Desonide—Testolactone—CYP19A1—prostate cancer	6.7e-05	0.0326	CrCbGaD
Desonide—Mediastinal disorder—Etoposide—prostate cancer	6.69e-05	0.00153	CcSEcCtD
Desonide—Nervous system disorder—Estradiol—prostate cancer	6.67e-05	0.00153	CcSEcCtD
Desonide—Infestation NOS—Capecitabine—prostate cancer	6.65e-05	0.00152	CcSEcCtD
Desonide—Infestation—Capecitabine—prostate cancer	6.65e-05	0.00152	CcSEcCtD
Desonide—Dexamethasone—CYP3A43—prostate cancer	6.62e-05	0.0322	CrCbGaD
Desonide—Skin disorder—Estradiol—prostate cancer	6.61e-05	0.00151	CcSEcCtD
Desonide—Hyperhidrosis—Estradiol—prostate cancer	6.57e-05	0.00151	CcSEcCtD
Desonide—Rash—Ethinyl Estradiol—prostate cancer	6.57e-05	0.00151	CcSEcCtD
Desonide—Dermatitis—Ethinyl Estradiol—prostate cancer	6.57e-05	0.0015	CcSEcCtD
Desonide—NR3C1—Circadian Clock—HIF1A—prostate cancer	6.56e-05	0.00463	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—prostate cancer	6.54e-05	0.00462	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—prostate cancer	6.54e-05	0.00462	CbGpPWpGaD
Desonide—Headache—Ethinyl Estradiol—prostate cancer	6.53e-05	0.0015	CcSEcCtD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—prostate cancer	6.5e-05	0.00459	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL10—prostate cancer	6.42e-05	0.00453	CbGpPWpGaD
Desonide—Infection—Mitoxantrone—prostate cancer	6.3e-05	0.00144	CcSEcCtD
Desonide—Skin disorder—Mitoxantrone—prostate cancer	6.15e-05	0.00141	CcSEcCtD
Desonide—Hyperhidrosis—Mitoxantrone—prostate cancer	6.13e-05	0.0014	CcSEcCtD
Desonide—Pharyngitis—Docetaxel—prostate cancer	6.12e-05	0.0014	CcSEcCtD
Desonide—Oedema peripheral—Docetaxel—prostate cancer	6.07e-05	0.00139	CcSEcCtD
Desonide—Pruritus—Goserelin—prostate cancer	6.07e-05	0.00139	CcSEcCtD
Desonide—Pruritus—Conjugated Estrogens—prostate cancer	6.01e-05	0.00138	CcSEcCtD
Desonide—Hyperglycaemia—Prednisone—prostate cancer	5.99e-05	0.00137	CcSEcCtD
Desonide—Pharyngitis—Capecitabine—prostate cancer	5.92e-05	0.00136	CcSEcCtD
Desonide—Oedema peripheral—Capecitabine—prostate cancer	5.88e-05	0.00135	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—prostate cancer	5.87e-05	0.00415	CbGpPWpGaD
Desonide—Pain—Estradiol—prostate cancer	5.82e-05	0.00133	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—prostate cancer	5.71e-05	0.00404	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—prostate cancer	5.71e-05	0.00403	CbGpPWpGaD
Desonide—Cough—Etoposide—prostate cancer	5.64e-05	0.00129	CcSEcCtD
Desonide—Mediastinal disorder—Docetaxel—prostate cancer	5.56e-05	0.00127	CcSEcCtD
Desonide—NR3C1—Adipogenesis—NCOA2—prostate cancer	5.54e-05	0.00391	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—CREBBP—prostate cancer	5.52e-05	0.0039	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—prostate cancer	5.51e-05	0.00389	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	5.46e-05	0.00125	CcSEcCtD
Desonide—Clocortolone—NR3C1—prostate cancer	5.43e-05	0.0264	CrCbGaD
Desonide—Prednicarbate—NR3C1—prostate cancer	5.43e-05	0.0264	CrCbGaD
Desonide—Pain—Mitoxantrone—prostate cancer	5.42e-05	0.00124	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—HIF1A—prostate cancer	5.41e-05	0.00382	CbGpPWpGaD
Desonide—Rash—Goserelin—prostate cancer	5.41e-05	0.00124	CcSEcCtD
Desonide—Dermatitis—Goserelin—prostate cancer	5.4e-05	0.00124	CcSEcCtD
Desonide—Mental disorder—Docetaxel—prostate cancer	5.4e-05	0.00124	CcSEcCtD
Desonide—Mediastinal disorder—Capecitabine—prostate cancer	5.38e-05	0.00123	CcSEcCtD
Desonide—Headache—Goserelin—prostate cancer	5.37e-05	0.00123	CcSEcCtD
Desonide—NR3C1—Adipogenesis—GADD45A—prostate cancer	5.37e-05	0.00379	CbGpPWpGaD
Desonide—Erythema—Docetaxel—prostate cancer	5.37e-05	0.00123	CcSEcCtD
Desonide—NR3C1—Circadian Clock—CREBBP—prostate cancer	5.36e-05	0.00379	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—PLAU—prostate cancer	5.36e-05	0.00378	CbGpPWpGaD
Desonide—Rash—Conjugated Estrogens—prostate cancer	5.36e-05	0.00123	CcSEcCtD
Desonide—Dermatitis—Conjugated Estrogens—prostate cancer	5.35e-05	0.00123	CcSEcCtD
Desonide—Headache—Conjugated Estrogens—prostate cancer	5.32e-05	0.00122	CcSEcCtD
Desonide—Dexamethasone—ANXA1—prostate cancer	5.24e-05	0.0254	CrCbGaD
Desonide—Infection—Etoposide—prostate cancer	5.24e-05	0.0012	CcSEcCtD
Desonide—Mental disorder—Capecitabine—prostate cancer	5.23e-05	0.0012	CcSEcCtD
Desonide—Erythema—Capecitabine—prostate cancer	5.2e-05	0.00119	CcSEcCtD
Desonide—Asthma—Epirubicin—prostate cancer	5.2e-05	0.00119	CcSEcCtD
Desonide—Diflorasone—NR3C1—prostate cancer	5.14e-05	0.025	CrCbGaD
Desonide—Skin disorder—Etoposide—prostate cancer	5.12e-05	0.00117	CcSEcCtD
Desonide—Hyperhidrosis—Etoposide—prostate cancer	5.1e-05	0.00117	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	5.08e-05	0.00359	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—ESR1—prostate cancer	5.04e-05	0.00356	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—SERPINE1—prostate cancer	5.03e-05	0.00355	CbGpPWpGaD
Desonide—Desoximetasone—NR3C1—prostate cancer	5.01e-05	0.0244	CrCbGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—prostate cancer	5.01e-05	0.00354	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—prostate cancer	4.98e-05	0.00352	CbGpPWpGaD
Desonide—Loteprednol—NR3C1—prostate cancer	4.95e-05	0.0241	CrCbGaD
Desonide—Fludrocortisone—AR—prostate cancer	4.88e-05	0.0237	CrCbGaD
Desonide—NR3C1—Endoderm Differentiation—APC—prostate cancer	4.88e-05	0.00345	CbGpPWpGaD
Desonide—Upper respiratory tract infection—Epirubicin—prostate cancer	4.83e-05	0.00111	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—TBX5—prostate cancer	4.83e-05	0.00341	CbGpPWpGaD
Desonide—Pruritus—Estradiol—prostate cancer	4.81e-05	0.0011	CcSEcCtD
Desonide—Asthma—Doxorubicin—prostate cancer	4.81e-05	0.0011	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	4.72e-05	0.00334	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—MDM2—prostate cancer	4.69e-05	0.00331	CbGpPWpGaD
Desonide—Beclomethasone—CYP3A5—prostate cancer	4.69e-05	0.0228	CrCbGaD
Desonide—Hyperglycaemia—Epirubicin—prostate cancer	4.69e-05	0.00107	CcSEcCtD
Desonide—Cough—Docetaxel—prostate cancer	4.68e-05	0.00107	CcSEcCtD
Desonide—NR3C1—Adipogenesis—NCOA1—prostate cancer	4.67e-05	0.0033	CbGpPWpGaD
Desonide—Mental disorder—Prednisone—prostate cancer	4.66e-05	0.00107	CcSEcCtD
Desonide—Infestation—Epirubicin—prostate cancer	4.63e-05	0.00106	CcSEcCtD
Desonide—Infestation NOS—Epirubicin—prostate cancer	4.63e-05	0.00106	CcSEcCtD
Desonide—Erythema—Prednisone—prostate cancer	4.63e-05	0.00106	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.54e-05	0.00104	CcSEcCtD
Desonide—Cough—Capecitabine—prostate cancer	4.53e-05	0.00104	CcSEcCtD
Desonide—Pain—Etoposide—prostate cancer	4.51e-05	0.00103	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—prostate cancer	4.49e-05	0.00317	CbGpPWpGaD
Desonide—Upper respiratory tract infection—Doxorubicin—prostate cancer	4.47e-05	0.00102	CcSEcCtD
Desonide—Sweating—Epirubicin—prostate cancer	4.44e-05	0.00102	CcSEcCtD
Desonide—NR3C1—Adipogenesis—RXRA—prostate cancer	4.44e-05	0.00314	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.39e-05	0.00101	CcSEcCtD
Desonide—Flurandrenolide—NR3C1—prostate cancer	4.39e-05	0.0213	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—ESR2—prostate cancer	4.38e-05	0.00309	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—prostate cancer	4.37e-05	0.00309	CbGpPWpGaD
Desonide—Infection—Docetaxel—prostate cancer	4.35e-05	0.000997	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—TH—prostate cancer	4.35e-05	0.00307	CbGpPWpGaD
Desonide—Hyperglycaemia—Doxorubicin—prostate cancer	4.34e-05	0.000994	CcSEcCtD
Desonide—Nervous system disorder—Docetaxel—prostate cancer	4.3e-05	0.000984	CcSEcCtD
Desonide—Rash—Estradiol—prostate cancer	4.29e-05	0.000983	CcSEcCtD
Desonide—Infestation—Doxorubicin—prostate cancer	4.29e-05	0.000982	CcSEcCtD
Desonide—Infestation NOS—Doxorubicin—prostate cancer	4.29e-05	0.000982	CcSEcCtD
Desonide—Dermatitis—Estradiol—prostate cancer	4.28e-05	0.000982	CcSEcCtD
Desonide—Headache—Estradiol—prostate cancer	4.26e-05	0.000976	CcSEcCtD
Desonide—Skin disorder—Docetaxel—prostate cancer	4.25e-05	0.000975	CcSEcCtD
Desonide—Hydrocortamate—NR3C1—prostate cancer	4.25e-05	0.0206	CrCbGaD
Desonide—Infection—Capecitabine—prostate cancer	4.21e-05	0.000966	CcSEcCtD
Desonide—Nervous system disorder—Capecitabine—prostate cancer	4.16e-05	0.000953	CcSEcCtD
Desonide—Pharyngitis—Epirubicin—prostate cancer	4.13e-05	0.000946	CcSEcCtD
Desonide—Skin disorder—Capecitabine—prostate cancer	4.12e-05	0.000944	CcSEcCtD
Desonide—Sweating—Doxorubicin—prostate cancer	4.11e-05	0.000942	CcSEcCtD
Desonide—Hyperhidrosis—Capecitabine—prostate cancer	4.1e-05	0.00094	CcSEcCtD
Desonide—Oedema peripheral—Epirubicin—prostate cancer	4.1e-05	0.000939	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—EGR1—prostate cancer	4.1e-05	0.00289	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—prostate cancer	4.03e-05	0.00285	CbGpPWpGaD
Desonide—Rash—Mitoxantrone—prostate cancer	4e-05	0.000916	CcSEcCtD
Desonide—Dermatitis—Mitoxantrone—prostate cancer	3.99e-05	0.000915	CcSEcCtD
Desonide—Headache—Mitoxantrone—prostate cancer	3.97e-05	0.00091	CcSEcCtD
Desonide—Budesonide—NR3C1—prostate cancer	3.95e-05	0.0192	CrCbGaD
Desonide—Amcinonide—NR3C1—prostate cancer	3.95e-05	0.0192	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	3.93e-05	0.00278	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.91e-05	0.000897	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—GJA1—prostate cancer	3.9e-05	0.00275	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—prostate cancer	3.89e-05	0.00275	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—AR—prostate cancer	3.87e-05	0.00273	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—LPL—prostate cancer	3.84e-05	0.00271	CbGpPWpGaD
Desonide—Pharyngitis—Doxorubicin—prostate cancer	3.82e-05	0.000875	CcSEcCtD
Desonide—Oedema peripheral—Doxorubicin—prostate cancer	3.79e-05	0.000869	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—EP300—prostate cancer	3.76e-05	0.00266	CbGpPWpGaD
Desonide—Mometasone—NR3C1—prostate cancer	3.75e-05	0.0182	CrCbGaD
Desonide—Infection—Prednisone—prostate cancer	3.75e-05	0.00086	CcSEcCtD
Desonide—Mediastinal disorder—Epirubicin—prostate cancer	3.75e-05	0.000859	CcSEcCtD
Desonide—Pain—Docetaxel—prostate cancer	3.75e-05	0.000858	CcSEcCtD
Desonide—Pruritus—Etoposide—prostate cancer	3.73e-05	0.000855	CcSEcCtD
Desonide—Rimexolone—NR3C1—prostate cancer	3.71e-05	0.018	CrCbGaD
Desonide—Nervous system disorder—Prednisone—prostate cancer	3.7e-05	0.000849	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	3.69e-05	0.0026	CbGpPWpGaD
Desonide—Skin disorder—Prednisone—prostate cancer	3.67e-05	0.000841	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—SRC—prostate cancer	3.66e-05	0.00258	CbGpPWpGaD
Desonide—Hyperhidrosis—Prednisone—prostate cancer	3.65e-05	0.000837	CcSEcCtD
Desonide—NR3C1—Circadian Clock—EP300—prostate cancer	3.65e-05	0.00258	CbGpPWpGaD
Desonide—Mental disorder—Epirubicin—prostate cancer	3.64e-05	0.000835	CcSEcCtD
Desonide—Pain—Capecitabine—prostate cancer	3.63e-05	0.000831	CcSEcCtD
Desonide—Erythema—Epirubicin—prostate cancer	3.62e-05	0.00083	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CXCL8—prostate cancer	3.51e-05	0.00248	CbGpPWpGaD
Desonide—Fluocinonide—NR3C1—prostate cancer	3.5e-05	0.017	CrCbGaD
Desonide—Beclomethasone—NR3C1—prostate cancer	3.5e-05	0.017	CrCbGaD
Desonide—Mediastinal disorder—Doxorubicin—prostate cancer	3.47e-05	0.000795	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CDKN1B—prostate cancer	3.43e-05	0.00242	CbGpPWpGaD
Desonide—Fluocinolone Acetonide—NR3C1—prostate cancer	3.4e-05	0.0165	CrCbGaD
Desonide—Alclometasone—NR3C1—prostate cancer	3.4e-05	0.0165	CrCbGaD
Desonide—NR3C1—Adipogenesis—PPARA—prostate cancer	3.39e-05	0.0024	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL10—prostate cancer	3.38e-05	0.00239	CbGpPWpGaD
Desonide—Mental disorder—Doxorubicin—prostate cancer	3.37e-05	0.000773	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—IL2—prostate cancer	3.35e-05	0.00237	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—BAZ2A—prostate cancer	3.35e-05	0.00237	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ZNF160—prostate cancer	3.35e-05	0.00237	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SSR2—prostate cancer	3.35e-05	0.00237	CbGpPWpGaD
Desonide—Erythema—Doxorubicin—prostate cancer	3.35e-05	0.000768	CcSEcCtD
Desonide—Rash—Etoposide—prostate cancer	3.32e-05	0.000762	CcSEcCtD
Desonide—Dermatitis—Etoposide—prostate cancer	3.32e-05	0.000761	CcSEcCtD
Desonide—NR3C1—Endoderm Differentiation—CTNNB1—prostate cancer	3.31e-05	0.00234	CbGpPWpGaD
Desonide—Clobetasol propionate—NR3C1—prostate cancer	3.31e-05	0.0161	CrCbGaD
Desonide—Flunisolide—NR3C1—prostate cancer	3.31e-05	0.0161	CrCbGaD
Desonide—Fludrocortisone—NR3C1—prostate cancer	3.31e-05	0.0161	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—prostate cancer	3.31e-05	0.00234	CbGpPWpGaD
Desonide—Headache—Etoposide—prostate cancer	3.3e-05	0.000757	CcSEcCtD
Desonide—NR3C1—Adipogenesis—HIF1A—prostate cancer	3.3e-05	0.00233	CbGpPWpGaD
Desonide—Paramethasone—NR3C1—prostate cancer	3.27e-05	0.0159	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—CCND1—prostate cancer	3.27e-05	0.00231	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CTNNB1—prostate cancer	3.24e-05	0.00229	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—LEP—prostate cancer	3.22e-05	0.00227	CbGpPWpGaD
Desonide—Ciclesonide—NR3C1—prostate cancer	3.22e-05	0.0156	CrCbGaD
Desonide—Fluorometholone—NR3C1—prostate cancer	3.19e-05	0.0155	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—MMP9—prostate cancer	3.17e-05	0.00224	CbGpPWpGaD
Desonide—Cough—Epirubicin—prostate cancer	3.16e-05	0.000724	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—PTEN—prostate cancer	3.16e-05	0.00223	CbGpPWpGaD
Desonide—Pruritus—Docetaxel—prostate cancer	3.1e-05	0.00071	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—prostate cancer	3.09e-05	0.00218	CbGpPWpGaD
Desonide—Methylprednisolone—NR3C1—prostate cancer	3.09e-05	0.015	CrCbGaD
Desonide—NR3C1—Gene Expression—HNRNPH1—prostate cancer	3.07e-05	0.00217	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.06e-05	0.000701	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—EP300—prostate cancer	3.01e-05	0.00213	CbGpPWpGaD
Desonide—Dexamethasone—CYP17A1—prostate cancer	3.01e-05	0.0146	CrCbGaD
Desonide—Clobetasol propionate—CYP1A1—prostate cancer	3.01e-05	0.0146	CrCbGaD
Desonide—Pruritus—Capecitabine—prostate cancer	3e-05	0.000688	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	2.96e-05	0.00209	CbGpPWpGaD
Desonide—Infection—Epirubicin—prostate cancer	2.94e-05	0.000673	CcSEcCtD
Desonide—Cough—Doxorubicin—prostate cancer	2.92e-05	0.00067	CcSEcCtD
Desonide—Nervous system disorder—Epirubicin—prostate cancer	2.9e-05	0.000664	CcSEcCtD
Desonide—NR3C1—Adipogenesis—IRS1—prostate cancer	2.87e-05	0.00203	CbGpPWpGaD
Desonide—Skin disorder—Epirubicin—prostate cancer	2.87e-05	0.000658	CcSEcCtD
Desonide—Hyperhidrosis—Epirubicin—prostate cancer	2.86e-05	0.000655	CcSEcCtD
Desonide—NR3C1—Gene Expression—NFIC—prostate cancer	2.85e-05	0.00201	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	2.85e-05	0.00201	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.83e-05	0.000649	CcSEcCtD
Desonide—Prednisolone—CYP2A6—prostate cancer	2.82e-05	0.0137	CrCbGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	2.81e-05	0.00199	CbGpPWpGaD
Desonide—Hydrocortisone—SHBG—prostate cancer	2.8e-05	0.0136	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	2.79e-05	0.00197	CbGpPWpGaD
Desonide—Rash—Docetaxel—prostate cancer	2.76e-05	0.000633	CcSEcCtD
Desonide—Dermatitis—Docetaxel—prostate cancer	2.76e-05	0.000632	CcSEcCtD
Desonide—NR3C1—Adipogenesis—INS—prostate cancer	2.75e-05	0.00194	CbGpPWpGaD
Desonide—Headache—Docetaxel—prostate cancer	2.74e-05	0.000629	CcSEcCtD
Desonide—Infection—Doxorubicin—prostate cancer	2.72e-05	0.000622	CcSEcCtD
Desonide—NR3C1—Gene Expression—RPN2—prostate cancer	2.68e-05	0.00189	CbGpPWpGaD
Desonide—Nervous system disorder—Doxorubicin—prostate cancer	2.68e-05	0.000614	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	2.68e-05	0.00189	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	2.68e-05	0.00189	CbGpPWpGaD
Desonide—Rash—Capecitabine—prostate cancer	2.67e-05	0.000613	CcSEcCtD
Desonide—Pruritus—Prednisone—prostate cancer	2.67e-05	0.000613	CcSEcCtD
Desonide—Dermatitis—Capecitabine—prostate cancer	2.67e-05	0.000612	CcSEcCtD
Desonide—NR3C1—Adipogenesis—IGF1—prostate cancer	2.66e-05	0.00188	CbGpPWpGaD
Desonide—Headache—Capecitabine—prostate cancer	2.66e-05	0.000609	CcSEcCtD
Desonide—Skin disorder—Doxorubicin—prostate cancer	2.66e-05	0.000609	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	2.65e-05	0.00187	CbGpPWpGaD
Desonide—Hyperhidrosis—Doxorubicin—prostate cancer	2.64e-05	0.000606	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	2.64e-05	0.00186	CbGpPWpGaD
Desonide—Betamethasone—CYP19A1—prostate cancer	2.63e-05	0.0128	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	2.62e-05	0.00185	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	2.62e-05	0.00185	CbGpPWpGaD
Desonide—Triamcinolone—NR3C1—prostate cancer	2.6e-05	0.0126	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	2.58e-05	0.00182	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—QARS—prostate cancer	2.54e-05	0.00179	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	2.54e-05	0.00179	CbGpPWpGaD
Desonide—Pain—Epirubicin—prostate cancer	2.53e-05	0.000579	CcSEcCtD
Desonide—NR3C1—Adipogenesis—SERPINE1—prostate cancer	2.53e-05	0.00178	CbGpPWpGaD
Desonide—Hydrocortamate—CYP3A4—prostate cancer	2.46e-05	0.012	CrCbGaD
Desonide—Rash—Prednisone—prostate cancer	2.38e-05	0.000546	CcSEcCtD
Desonide—Dermatitis—Prednisone—prostate cancer	2.38e-05	0.000545	CcSEcCtD
Desonide—Headache—Prednisone—prostate cancer	2.37e-05	0.000542	CcSEcCtD
Desonide—Prednisone—NR3C1—prostate cancer	2.36e-05	0.0115	CrCbGaD
Desonide—Pain—Doxorubicin—prostate cancer	2.34e-05	0.000536	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	2.33e-05	0.00165	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	2.33e-05	0.00164	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—TBX5—prostate cancer	2.32e-05	0.00164	CbGpPWpGaD
Desonide—Budesonide—CYP3A4—prostate cancer	2.29e-05	0.0111	CrCbGaD
Desonide—Hydrocortisone—CYP3A5—prostate cancer	2.23e-05	0.0108	CrCbGaD
Desonide—Prednisolone—NR3C1—prostate cancer	2.18e-05	0.0106	CrCbGaD
Desonide—NR3C1—Gene Expression—EIF3H—prostate cancer	2.16e-05	0.00153	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	2.15e-05	0.00152	CbGpPWpGaD
Desonide—Prednisone—CYP2C19—prostate cancer	2.15e-05	0.0105	CrCbGaD
Desonide—Betamethasone—NR3C1—prostate cancer	2.13e-05	0.0104	CrCbGaD
Desonide—Pruritus—Epirubicin—prostate cancer	2.09e-05	0.000479	CcSEcCtD
Desonide—Dexamethasone—CYP1B1—prostate cancer	2.08e-05	0.0101	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	2.02e-05	0.00143	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—CTNNB1—prostate cancer	1.97e-05	0.00139	CbGpPWpGaD
Desonide—Alclometasone—CYP3A4—prostate cancer	1.97e-05	0.00958	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	1.97e-05	0.00139	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.95e-05	0.00138	CbGpPWpGaD
Desonide—Pruritus—Doxorubicin—prostate cancer	1.93e-05	0.000443	CcSEcCtD
Desonide—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.93e-05	0.00136	CbGpPWpGaD
Desonide—Flunisolide—CYP3A4—prostate cancer	1.92e-05	0.00933	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.9e-05	0.00134	CbGpPWpGaD
Desonide—Paramethasone—CYP3A4—prostate cancer	1.9e-05	0.00921	CrCbGaD
Desonide—Ciclesonide—CYP3A4—prostate cancer	1.87e-05	0.00906	CrCbGaD
Desonide—Rash—Epirubicin—prostate cancer	1.86e-05	0.000427	CcSEcCtD
Desonide—Dermatitis—Epirubicin—prostate cancer	1.86e-05	0.000427	CcSEcCtD
Desonide—Headache—Epirubicin—prostate cancer	1.85e-05	0.000424	CcSEcCtD
Desonide—Fluorometholone—CYP3A4—prostate cancer	1.85e-05	0.00899	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.85e-05	0.00131	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.85e-05	0.00131	CbGpPWpGaD
Desonide—Methylprednisolone—CYP3A4—prostate cancer	1.79e-05	0.00869	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.77e-05	0.00125	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—TET2—prostate cancer	1.76e-05	0.00124	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MBD2—prostate cancer	1.76e-05	0.00124	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.74e-05	0.00123	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPL12—prostate cancer	1.73e-05	0.00122	CbGpPWpGaD
Desonide—Rash—Doxorubicin—prostate cancer	1.72e-05	0.000395	CcSEcCtD
Desonide—Dermatitis—Doxorubicin—prostate cancer	1.72e-05	0.000395	CcSEcCtD
Desonide—NR3C1—Adipogenesis—STAT3—prostate cancer	1.72e-05	0.00121	CbGpPWpGaD
Desonide—Headache—Doxorubicin—prostate cancer	1.71e-05	0.000392	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.71e-05	0.0012	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.7e-05	0.0012	CbGpPWpGaD
Desonide—Hydrocortisone—NR3C1—prostate cancer	1.66e-05	0.00808	CrCbGaD
Desonide—Dexamethasone—CYP3A5—prostate cancer	1.66e-05	0.00807	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.63e-05	0.00115	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.62e-05	0.00115	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.62e-05	0.00114	CbGpPWpGaD
Desonide—Dexamethasone—CYP2A6—prostate cancer	1.61e-05	0.00781	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.6e-05	0.00113	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.59e-05	0.00113	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EIF3A—prostate cancer	1.59e-05	0.00112	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.59e-05	0.00112	CbGpPWpGaD
Desonide—Dexamethasone—CYP19A1—prostate cancer	1.53e-05	0.00743	CrCbGaD
Desonide—Triamcinolone—CYP3A4—prostate cancer	1.51e-05	0.00733	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.5e-05	0.00106	CbGpPWpGaD
Desonide—Triamcinolone—PTGS2—prostate cancer	1.48e-05	0.00717	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.47e-05	0.00104	CbGpPWpGaD
Desonide—Prednisone—CYP3A4—prostate cancer	1.37e-05	0.00665	CrCbGaD
Desonide—NR3C1—Gene Expression—DNMT3B—prostate cancer	1.34e-05	0.000943	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPL10—prostate cancer	1.31e-05	0.000925	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	1.29e-05	0.000908	CbGpPWpGaD
Desonide—Prednisolone—CYP3A4—prostate cancer	1.26e-05	0.00613	CrCbGaD
Desonide—NR3C1—Gene Expression—NPPA—prostate cancer	1.24e-05	0.000877	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HIST1H4H—prostate cancer	1.24e-05	0.000877	CbGpPWpGaD
Desonide—Dexamethasone—NR3C1—prostate cancer	1.24e-05	0.00602	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	1.24e-05	0.000875	CbGpPWpGaD
Desonide—Betamethasone—CYP3A4—prostate cancer	1.24e-05	0.006	CrCbGaD
Desonide—NR3C1—Gene Expression—MED12—prostate cancer	1.22e-05	0.000862	CbGpPWpGaD
Desonide—Betamethasone—PTGS2—prostate cancer	1.21e-05	0.00588	CrCbGaD
Desonide—NR3C1—Adipogenesis—IL6—prostate cancer	1.2e-05	0.000849	CbGpPWpGaD
Desonide—Dexamethasone—CYP2E1—prostate cancer	1.14e-05	0.00554	CrCbGaD
Desonide—Dexamethasone—CYP2C19—prostate cancer	1.13e-05	0.00549	CrCbGaD
Desonide—Dexamethasone—CYP1A1—prostate cancer	1.13e-05	0.00547	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	1.12e-05	0.000793	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	1.04e-05	0.000733	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPS19—prostate cancer	1.04e-05	0.000733	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—DNMT1—prostate cancer	9.92e-06	0.000701	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	9.83e-06	0.000695	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NCOA2—prostate cancer	9.74e-06	0.000688	CbGpPWpGaD
Desonide—Hydrocortisone—CYP3A4—prostate cancer	9.64e-06	0.00469	CrCbGaD
Desonide—NR3C1—Gene Expression—EZH2—prostate cancer	9.61e-06	0.000679	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PARP1—prostate cancer	9.41e-06	0.000664	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	9.22e-06	0.000651	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR2—prostate cancer	8.91e-06	0.000629	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HSPA1A—prostate cancer	8.91e-06	0.000629	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NCOA1—prostate cancer	8.21e-06	0.00058	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AR—prostate cancer	7.87e-06	0.000556	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RXRA—prostate cancer	7.81e-06	0.000551	CbGpPWpGaD
Desonide—Dexamethasone—CYP3A4—prostate cancer	7.19e-06	0.00349	CrCbGaD
Desonide—NR3C1—Gene Expression—SIRT1—prostate cancer	7.17e-06	0.000507	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—VDR—prostate cancer	7.07e-06	0.000499	CbGpPWpGaD
Desonide—Dexamethasone—PTGS2—prostate cancer	7.04e-06	0.00342	CrCbGaD
Desonide—NR3C1—Gene Expression—ERCC2—prostate cancer	6.47e-06	0.000457	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PPARA—prostate cancer	5.96e-06	0.000421	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	5.84e-06	0.000412	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR1—prostate cancer	5.4e-06	0.000382	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—CREBBP—prostate cancer	4.74e-06	0.000334	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SERPINE1—prostate cancer	4.44e-06	0.000314	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MYC—prostate cancer	2.81e-06	0.000198	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AKT1—prostate cancer	1.95e-06	0.000138	CbGpPWpGaD
